Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation

Europace

Volumn 15, Issue 6, 2013, Pages 857-864

  Larsen, Alf Inge ^a,b   Lindal, Sigurd ^c   Myreng, Kate ^c   Ogne, Christer ^a   Kvaløy, Jan Terje ^d   Munk, Peter Scott ^a,b   Aukrust, Pål ^e,f,g   Yndestad, Arne ^e   Dickstein, Kenneth ^a,b   Nilsen, Dennis W T ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d UNIVERSITY OF STAVANGER   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

Author keywords

Chronic heart failure; CRT; Cytokines; Inflammation; Peak VO2; Skeletal muscle; VE VCO2 slope

Indexed keywords

CARBON DIOXIDE;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD SAMPLING; CAPILLARY DENSITY; CARDIAC RESYNCHRONIZATION THERAPY; CELL DENSITY; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; IMPLANTED HEART PACEMAKER; INFLAMMATION; LUNG MINUTE VOLUME; MALE; MITOCHONDRION; OUTPATIENT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QRS COMPLEX; SKELETAL MUSCLE;

CHRONIC HEART FAILURE; CRT; CYTOKINES; INFLAMMATION; PEAK VO2; SKELETAL MUSCLE; VE/VCO2 SLOPE;

AGED; CAPILLARIES; CARBON DIOXIDE; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; MUSCLE, SKELETAL; MYOSITIS; OXYGEN CONSUMPTION; PULMONARY VENTILATION; TREATMENT OUTCOME;

EID: 84878299532     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus428     Document Type: Article

References (40)

1. Packer M. The neurohumoral hypothesis: a theory to explain the mechanism of the progression in heart failure. J Am Coll Cardiol 1992;20:248-54.
2. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996;2:243-9.
3. Neta R, Oppenheimer JJ, Durum SK. The cytokine concept: historical perspectives and current status of the clonal cytokines. In: Stanley C, ed. Lymphokines and the Immune Response. Boca Raton, FL: CRC Press; 1990. p29-42.
4. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotrop effect of cytokines mediated by nitric oxide. Science 1992;257:387-9.
5. Coats AJ, Clark AL, Piepoli M, Volterrani M, Poole-Wilson PA. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994;72(2 Suppl.):S36-9.
6. Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751-9.
7. Hambrecht R, Niebauer J, Fiehn E, Kälberer B, Offner B, Hauer K et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995; 25:1239-49.
8. Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004;328:189.
9. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ et al., HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301:1439-50.
10. Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M et al. Functional capacity and changes in the neurohormonal and cytokine status after longterm CRT in heart failure patients. Int J Cardiol 2007;121:68-73.
11. De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK et al. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. J Card Fail 2008;14:9-18.
12. Boriani G, Müller CP, Seidl KH, Grove R, Vogt J, Danschel W et al., Resynchroni-zation for theHemodYnamic Treatment for Heart Failure Management II Investigators. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resyn-chronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J 2006;151:1050-8.
13. Cazeau S, Gras D, Lazarus A, Ritter P, Mugica J. Multisite stimulation for correction of cardiac asynchrony. Heart 2000;84:579-81.
14. Larsen AI, Aarsland T, Kristiansen M, Haugland A, Dickstein K. Assessing the effect of exercise training in men with heart failure; comparison of maximal, submaximal and endurance exercise protocols. Eur Heart J 2001;22:684-92.
15. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J 2004; 147:354-60.
16. Larsen AI, Lindal S, Aukrust P, Aarsland T, Dickstein K. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol 2002;83:25-32.
17. Auricchio A, Prinzen FW. Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J 2011;75:521-7.
18. Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 1991;66:443-7.
19. Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O et al. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 1996;19:1748-57.
20. Leclercq C, Cazeau S, Le Breton H, Ritter P, Mabo P, Gras D et al. Acute hemo-dynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825-31.
21. Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen AK et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol 1998;21: 2249-55.
22. Chwyczko T, Sterliński M, Maciag A, Firek B, Labecka A, Jankowska A et al. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure. Kardiol Pol 2008;66:406-12.
23. Wilson JR, Rayos G, Yeoh TK, Gothard P. Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates. J Am Coll Cardiol 1995;26:429-35.
24. Guazzi M, Casali M, Berti F, Rossoni G, Colonna VD, Guazzi MD. Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients. Clin Pharmacol Ther 2008;83:336-41.
25. Erol-Yilmaz A, Atasever B, Mathura K, Lindeboom J, Wilde A, Ince C et al. Cardiac resynchronization improves microcirculation. J Card Fail 2007;13:95-9.
26. Duscha BD, Kraus WE, Keteyian SJ, Sullivan MJ, Green HJ, Schachat FH et al. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 1999;33:1956-63.
27. Mahy IR, Tooke JE. Peripheral microvascular function in human heart failure. Clin Sci 1995;88:501-8.
28. Toft I, Lindal S, Bønaa KH, Jenssen T. Quantitative measurement of muscle fiber composition in a normal population. Muscle Nerve 2003;28:101-8.
29. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1990;322:100-10.
30. Garesse R, Vallejo CG. Animal mitochondrial biogenesis and function: a regulatory cross-talk between two genomes. Gene 2001;263:1-16.
31. Hood DA. Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 2001;90:1137-57.
32. Duguez S, Féasson L, Denis C, Freyssenet D. Mitochondrial biogenesis during skeletal muscle regeneration. Am J Physiol Endocrinol Metab 2002;282:E802-9.
33. Pilegaard H, Saltin B, Neufer PD. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 2003;546:851-8.
34. Costford SR, Bajpeyi S, Pasarica M, Albarado DC, Thomas SC, Xie H et al. Skeletal muscle NAMPT is induced by exercise in humans. Am J Physiol Endocrinol Metab 2010;298:E117-26.
35. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E et al. Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005;111:1763-70.
36. Gielen S, Adams V, Möbius-Winkler S, Linke A, Erbs S, Yu J et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003;42:861-8.
37. Patwala AY, Woods PR, Sharp L, Goldspink DF, Tan LB, Wright DJ. Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured exercise training: a randomized controlled study. J Am Coll Cardiol. 2009;53: 2332-9.
38. Michelucci A, Ricciardi G, Sofi F, Gori AM, Pirolo F, Pieragnoli P et al. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy. J Cardiac Fail 2007;13: 207-10.
39. Lappegård KT, Bjørnstad H. Anti-inflammatory effect of cardiac resynchronization therapy. Pacing Clin Electrophysiol 2006;29:753-8.
40. Theodorakis GN, Flevari P, Kroupis C, Adamopoulos S, Livanis EG, Kostopoulou A et al. Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure. Pacing Clin Electrophysiol 2006;29: 255-61.